<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药渡 | wechat-feeds</title><link>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</link><description>药渡以自有药物大数据为依托，对上市及临床在研药物、药物研究进展和重要药物市场商业动态作出信息整合分析，传递药物创新一手资讯</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 27 May 2021 11:23:09 +0800</pubDate><image><url>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</url><title>药渡 | wechat-feeds</title><link>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>干法制粒技术探讨</title><link>https://mp.weixin.qq.com/s/Nm5W35KdaoT6VyEeEODpKg</link><description></description><content:encoded><![CDATA[干法制粒技术探讨]]></content:encoded><pubDate>Wed, 26 May 2021 21:05:20 +0800</pubDate></item><item><title>紧急通知！6月10日后，暂停新冠疫苗第一针接种</title><link>https://mp.weixin.qq.com/s/gRzJrzykjPlAfdTbrPMKww</link><description></description><content:encoded><![CDATA[紧急通知！6月10日后，暂停新冠疫苗第一针接种]]></content:encoded><pubDate>Wed, 26 May 2021 21:05:20 +0800</pubDate></item><item><title>汇恩兰德为您提供全方位的滴眼剂CDMO服务！</title><link>https://mp.weixin.qq.com/s/jqdJRovkjNtdm3x28StUOQ</link><description></description><content:encoded><![CDATA[汇恩兰德为您提供全方位的滴眼剂CDMO服务！]]></content:encoded><pubDate>Wed, 26 May 2021 21:05:20 +0800</pubDate></item><item><title>【5月28日，线上直播】CDMO-药物商业化的必由之路</title><link>https://mp.weixin.qq.com/s/roISeSXgSsyNPH6u8Iyy4Q</link><description></description><content:encoded><![CDATA[【5月28日，线上直播】CDMO-药物商业化的必由之路]]></content:encoded><pubDate>Wed, 26 May 2021 21:05:20 +0800</pubDate></item><item><title>好书推荐 |《过程分析技术在生物制药工艺开发与生产中的应用》</title><link>https://mp.weixin.qq.com/s/My9NR3CBXMLzqQ7IcwNN9w</link><description></description><content:encoded><![CDATA[好书推荐 |《过程分析技术在生物制药工艺开发与生产中的应用》]]></content:encoded><pubDate>Wed, 26 May 2021 21:05:20 +0800</pubDate></item><item><title>药渡招聘 | 咨询合伙人</title><link>https://mp.weixin.qq.com/s/2XlFJeBBcFsdgebU24nCwg</link><description></description><content:encoded><![CDATA[药渡招聘 | 咨询合伙人]]></content:encoded><pubDate>Wed, 26 May 2021 21:05:20 +0800</pubDate></item><item><title>风风雨雨二十年，激酶抑制剂的未来在何方？</title><link>https://mp.weixin.qq.com/s/68qgR-FuKb3yn4K1mr4nrg</link><description></description><content:encoded><![CDATA[风风雨雨二十年，激酶抑制剂的未来在何方？]]></content:encoded><pubDate>Tue, 25 May 2021 20:34:34 +0800</pubDate></item><item><title>唏嘘现状！373家上市企业研发总投入竟不及罗氏一家</title><link>https://mp.weixin.qq.com/s/6r48klrRs2Ddc2MSrV62Mg</link><description></description><content:encoded><![CDATA[唏嘘现状！373家上市企业研发总投入竟不及罗氏一家]]></content:encoded><pubDate>Tue, 25 May 2021 20:34:34 +0800</pubDate></item><item><title>BFC出品 | 医疗健康行业资本市场周报</title><link>https://mp.weixin.qq.com/s/CGEjt_RgcIDxA9gWdHo_dA</link><description></description><content:encoded><![CDATA[BFC出品 | 医疗健康行业资本市场周报]]></content:encoded><pubDate>Tue, 25 May 2021 20:34:34 +0800</pubDate></item><item><title>药渡直播 | 创药蓝海风向标！BiG七周年即将倚天出鞘</title><link>https://mp.weixin.qq.com/s/pdg5_KEq-R9hEySFR3flmg</link><description></description><content:encoded><![CDATA[药渡直播 | 创药蓝海风向标！BiG七周年即将倚天出鞘]]></content:encoded><pubDate>Tue, 25 May 2021 20:34:34 +0800</pubDate></item><item><title>好书推荐 | 《化学试剂•化学药品手册》</title><link>https://mp.weixin.qq.com/s/SL6M4gcCkONz_Z-STZ15cg</link><description></description><content:encoded><![CDATA[好书推荐 | 《化学试剂•化学药品手册》]]></content:encoded><pubDate>Tue, 25 May 2021 20:34:34 +0800</pubDate></item><item><title>药渡招聘 | 咨询师</title><link>https://mp.weixin.qq.com/s/lCBQetCq5Q3MUb-U-1J8mg</link><description></description><content:encoded><![CDATA[药渡招聘 | 咨询师]]></content:encoded><pubDate>Tue, 25 May 2021 20:34:34 +0800</pubDate></item><item><title>DIA年会精彩回顾|泛生子精准助力新药研发，聚焦伴随诊断全球化</title><link>https://mp.weixin.qq.com/s/K4rcGw8VLNWP0Hdvtqg2Iw</link><description></description><content:encoded><![CDATA[DIA年会精彩回顾|泛生子精准助力新药研发，聚焦伴随诊断全球化]]></content:encoded><pubDate>Mon, 24 May 2021 18:19:50 +0800</pubDate></item><item><title>晶泰智播｜晶型预测技术及多元化的应用</title><link>https://mp.weixin.qq.com/s/6zxVAPKray3a68mvehErwQ</link><description></description><content:encoded><![CDATA[晶泰智播｜晶型预测技术及多元化的应用]]></content:encoded><pubDate>Mon, 24 May 2021 18:19:50 +0800</pubDate></item><item><title>最新会讯|首届医药创新发展与产业融合高峰论坛暨首届CXO全产业链服务发展论坛</title><link>https://mp.weixin.qq.com/s/67Cm7QtsH8moiUarrDQb8A</link><description></description><content:encoded><![CDATA[最新会讯|首届医药创新发展与产业融合高峰论坛暨首届CXO全产业链服务发展论坛]]></content:encoded><pubDate>Mon, 24 May 2021 18:19:50 +0800</pubDate></item><item><title>24日最新药品批件发布：磷丙泊酚二钠、阿昔替尼、利伐沙班、舒尼替尼、硼替佐米...</title><link>https://mp.weixin.qq.com/s/twZ71X8o4jWDQhS6245Pzw</link><description></description><content:encoded><![CDATA[24日最新药品批件发布：磷丙泊酚二钠、阿昔替尼、利伐沙班、舒尼替尼、硼替佐米...]]></content:encoded><pubDate>Mon, 24 May 2021 18:19:50 +0800</pubDate></item><item><title>好书推荐 |《新药化学全合成路线手册》</title><link>https://mp.weixin.qq.com/s/7mCy24_6fRXFX5x1RbvI5w</link><description></description><content:encoded><![CDATA[好书推荐 |《新药化学全合成路线手册》]]></content:encoded><pubDate>Mon, 24 May 2021 18:19:50 +0800</pubDate></item><item><title>药渡招聘 | 药学分析师</title><link>https://mp.weixin.qq.com/s/rH5m10qaJwXiUwfT6-FIaQ</link><description></description><content:encoded><![CDATA[药渡招聘 | 药学分析师]]></content:encoded><pubDate>Mon, 24 May 2021 18:19:50 +0800</pubDate></item><item><title>抗体发现过程中常见的工程化技术与策略</title><link>https://mp.weixin.qq.com/s/sA3EHhABiyTb-uh71Hi5xg</link><description></description><content:encoded><![CDATA[抗体发现过程中常见的工程化技术与策略]]></content:encoded><pubDate>Sun, 23 May 2021 19:21:19 +0800</pubDate></item><item><title>【Nature子刊】靶向RAS疗法的最新进展</title><link>https://mp.weixin.qq.com/s/OSgyHYHgax3nkZJHsiFk9Q</link><description></description><content:encoded><![CDATA[【Nature子刊】靶向RAS疗法的最新进展]]></content:encoded><pubDate>Sun, 23 May 2021 19:21:19 +0800</pubDate></item></channel></rss>